Blau Farmacêutica S.A.

BOVESPA:BLAU3 Stock Report

Market Cap: R$2.6b

Blau Farmacêutica Dividends and Buybacks

Dividend criteria checks 2/6

Blau Farmacêutica is a dividend paying company with a current yield of 4.98% that is well covered by earnings. Next payment date is on 31st December, 2024 with an ex-dividend date of 27th September, 2024.

Key information

5.0%

Dividend yield

0%

Buyback Yield

Total Shareholder Yield5.0%
Future Dividend Yield4.1%
Dividend Growth38.6%
Next dividend pay date31 Dec 24
Ex dividend date27 Sep 24
Dividend per shareR$0.748
Payout ratio10%

Recent dividend and buyback updates

Recent updates

Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 07
Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Nov 06
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Aug 29
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Jun 28
Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

Feb 01
Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

May 14
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Feb 24
Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Oct 14
Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Aug 17
Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, BLAU3 has been paying a dividend for less than 10 years.

Growing Dividend: BLAU3's dividend payments have increased, but the company has only paid a dividend for 3 years.


Dividend Yield vs Market

Blau Farmacêutica Dividend Yield vs Market
How does BLAU3 dividend yield compare to the market?
SegmentDividend Yield
Company (BLAU3)5.0%
Market Bottom 25% (BR)3.0%
Market Top 25% (BR)9.4%
Industry Average (Biotechs)2.3%
Analyst forecast (BLAU3) (up to 3 years)4.1%

Notable Dividend: BLAU3's dividend (4.98%) is higher than the bottom 25% of dividend payers in the BR market (2.95%).

High Dividend: BLAU3's dividend (4.98%) is low compared to the top 25% of dividend payers in the BR market (9.45%).


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (9.9%), BLAU3's dividend payments are thoroughly covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (151.2%), BLAU3's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies